FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11427711000001104: Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
41061401000001117 Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
41061501000001118 Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Is a Sulfasalazine 500mg tablets 112 tablet true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Is pack of Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has active ingredient Sulfasalazine false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has AMP Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has specific active ingredient Sulfasalazine true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets (Almus Pharmaceuticals Ltd) 112 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start